. home.aspx

NEWS

home.aspx
   


Vaccine for Lassa Fever Set To Be Trialed

October 25, 2019 / Technology Networks
SHARESHARESHARE

There is currently no vaccine for the Lassa arenavirus, which causes Lassa fever. This hemorrhagic fever, endemic in West Africa, infects up to 300,000 people each year. Given the urgency of the situation, scientists in the Biology of Viral Emerging Infections Unit and the Viral Genomics and Vaccination Unit at the Institut Pasteur evaluated the efficacy of several vaccine candidates. Following their analyses, they identified one of these vaccines, based on the measles platform, as being the most effective to enter clinical testing in humans as soon as possible. This raises hopes in the fight against a disease that claims between 5,000 and 6,000 lives every year. Lassa fever, a hemorrhagic fever caused by the Lassa virus (LASV), is responsible for several thousands of deaths in endemic countries in West Africa every year. The natural reservoir of the virus is a peridomestic rodent that lives near or inside homes, so contacts between humans and the infected reservoir in villages are fre...